Effect of Oligomeric Proanthocyanidin on the Antioxidant Status and Lung Function of Patients with Chronic Obstructive Pulmonary Disease

被引:27
作者
Lu, Meng-Chun [1 ,2 ,5 ]
Yang, Mei-Due [2 ,3 ,4 ,6 ]
Li, Ping-Chun [3 ,6 ]
Fan, Hsin-Yuan [3 ,6 ]
Huang, Hui-Ying [5 ]
Chan, Yin-Ching [1 ]
Bau, Da-Tian [4 ,7 ]
机构
[1] Providence Univ, Dept Food & Nutr, Taichung, Taiwan
[2] China Med Univ Hosp, Translat Med Res Ctr, Dept Clin Nutr, Taichung, Taiwan
[3] China Med Univ Hosp, Translat Med Res Ctr, Dept Surg, Taichung, Taiwan
[4] China Med Univ Hosp, Translat Med Res Ctr, Terry Fox Canc Res Lab, Taichung, Taiwan
[5] China Med Univ, Dept Nutr, Taichung, Taiwan
[6] China Med Univ, Dept Med, Taichung, Taiwan
[7] Asia Univ, Dept Bioinformat & Med Engn, Taichung, Taiwan
来源
IN VIVO | 2018年 / 32卷 / 04期
关键词
Oxidative status; chronic obstructive pulmonary disease; lipid profiles; lung function; oligomeric proanthocyanidin; GRAPE SEED PROANTHOCYANIDIN; OXIDATIVE STRESS; BREATH CONDENSATE; NATIONAL-HEALTH; EXTRACT; COPD; PARAOXONASE; APOPTOSIS; SMOKING; ASTHMA;
D O I
10.21873/invivo.11304
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background/Aim: Evidence exists that oxidative stress and oxidative damage play a pivotal role in chronic obstructive pulmonary disease (COPD). Oligomeric proanthocyanidins (OPCs) extracted from grape seeds have been shown to exhibit antioxidant capabilities greater than those of vitamin C and E. The objective of this study was to evaluate the effects of OPCs on antioxidant status and lung function in patients with COPD. Patients and Methods: Patients were supplemented with 150 mg/day OPC (n=13) orally or with a placebo (n=14) for 8 weeks in a randomized double-blind clinical design. Changes in anthropometric values, lung function, oxidative state, and lipid profiles were assessed after OPC or placebo treatment for 8 weeks. Results: The results showed that OPC supplementation significantly reduced the concentration of malondialdehyde, superoxide dismutase, and total cholesterol (TC)/high- density lipoprotein cholesterol (HDL-C) ratio. The concentration of HDL-C significantly increased in the OPC- treated group. The plasma triglyceride, TC and low-density lipoprotein cholesterol values and the activities of catalase and glutathione peroxidase also decreased, but did not significantly differ between the OPC- and placebo-treated groups. Lung function was not significantly different between the two groups after 8 weeks. Conclusion: OPC supplementation was effective in increasing the antioxidant capacity, in addition to improving the lipid profiles in patients with COPD.
引用
收藏
页码:753 / 758
页数:6
相关论文
共 50 条
  • [31] Serum cystatin C and indices of lung function in elderly Chinese men with chronic obstructive pulmonary disease
    Zhang, Meng
    Fu, Shu-Hong
    Cui, Hua
    Zhu, Bing-Po
    Liu, Lin
    Wang, De-Long
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2014, 26 (02) : 193 - 199
  • [32] Assessment of Nutritional Status in Chronic Obstructive Pulmonary Disease Patients
    Yazdanpanah, L.
    Shidfar, F.
    Moosavi, J. A.
    Heidarnazhad, H.
    Haghani, H.
    IRANIAN JOURNAL OF PUBLIC HEALTH, 2009, 38 (03) : 39 - 45
  • [33] Cognitive status among patients with chronic obstructive pulmonary disease
    Roncero, Carlos
    Isabel Campuzano, Ana
    Antonio Quintano, Jose
    Molina, Jesus
    Perez, Joselin
    Miravitlles, Marc
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2016, 11 : 543 - 551
  • [34] The Association Between TTV Load with Lung Function and Severity of Disease in Patients with Chronic Obstructive Pulmonary Disease
    Xie, Y.
    Xue, Q.
    Yu, Y.
    Zheng, Y.
    Gao, Z.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [35] Aquaporin 5 Polymorphisms and Rate of Lung Function Decline in Chronic Obstructive Pulmonary Disease
    Hansel, Nadia N.
    Sidhaye, Venkataramana
    Rafaels, Nicholas M.
    Gao, Li
    Gao, Peisong
    Williams, Renaldo
    Connett, John E.
    Beaty, Terri H.
    Mathias, Rasika A.
    Wise, Robert A.
    King, Landon S.
    Barnes, Kathleen C.
    PLOS ONE, 2010, 5 (12):
  • [36] Alterations in Lung Mast Cell Populations in Patients with Chronic Obstructive Pulmonary Disease
    Andersson, Cecilia K.
    Mori, Michiko
    Bjermer, Leif
    Lofdahl, Claes-Goran
    Erjefalt, Jonas S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181 (03) : 206 - 217
  • [37] Food for thought: optimal diet in patients with asthma and chronic obstructive pulmonary disease
    Vameghestahbanati, Motahareh
    Wang, Carolyn J.
    Sin, Don D.
    CURRENT OPINION IN PULMONARY MEDICINE, 2025, 31 (02) : 106 - 116
  • [38] Spirometric Predictors of Lung Function Decline and Mortality in Early Chronic Obstructive Pulmonary Disease
    Drummond, M. Bradley
    Hansel, Nadia N.
    Connett, John E.
    Scanlon, Paul D.
    Tashkin, Donald P.
    Wise, Robert A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2012, 185 (12) : 1301 - 1306
  • [39] PON1 gene polymorphisms in patients with chronic obstructive pulmonary disease
    Rajkovic, Marija Grdic
    Popovic-Grle, Sanja
    Dugac, Andrea Vukic
    Rogic, Dunja
    Rako, Ivana
    Antolic, Margareta Radic
    Berisa, Mirela
    Rumora, Lada
    JOURNAL OF CLINICAL PATHOLOGY, 2018, 71 (11) : 963 - 970
  • [40] Air Pollution Exposure and Daily Lung Function in Chronic Obstructive Pulmonary Disease Effect Modification by Eosinophil Level
    Nurhussien, Lina
    Kang, Choong-Min
    Koutrakis, Petros
    Coull, Brent A.
    Rice, Mary B.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2022, 19 (05) : 728 - 736